ProfileGDS4459 / ENSG00000161944
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 86% 83% 96% 90% 88% 85% 95% 93% 95% 96% 81% 94% 93% 87% 95% 82% 85% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.6886
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.2183
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.6796
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.9390
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.0488
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.5585
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.295
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.7693
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 98.1895
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 108.4896
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.2381
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.1194
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.8693
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.7187
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.2895
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.0782
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.4985